25 May 2013
Keywords: roche, zenapax, promising, asthma, swiss, drug, major
Article | 27 September 2004
Swiss drug major Roche and USA-based Protein Design Labs have signed a worldwide agreement to co-develop and commercialize the former's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
24 May 2013
© 2013 thepharmaletter.com